LTE4

(redirected from Leukotriene E4)
Also found in: Wikipedia.
AcronymDefinition
LTE4Leukotriene E4 (lipid mediator)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Austen, "Functional recognition of a distinct receptor preferential for leukotriene E4 in mice lacking the cysteinyl leukotriene 1 and 2 receptors," Proceedings of the National Academy of Sciences of the United States of America, vol.
Austen, "Identification of GPR99 protein as a potential third cysteinyl leukotriene receptor with a preference for leukotriene E4 ligand," The Journal of Biological Chemistry, vol.
Elevated basal leukotriene levels have been found in aspirin-sensitive patients, and during aspirin-induced reactions further elevations in leukotriene E4 levels have been documented.
Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects.
The CysLT1receptor antagonist montelukast blocks bronchoconstriction induced by inhaled leukotriene E4 in subjects with asthma.
Boyce, "Leukotriene E4 activates peroxisome proliferator-activated receptor and induces prostaglandin D2 generation by human mast cells," The Journal of Biological Chemistry, vol.
Akiyama, "Aspirin-intolerant asthma (AIA) assessment using the urinary biomarkers, leukotriene E4 (LTE4) and prostaglandin D2 (PGD2) metabolites," Allergology International, vol.
Ford-Hutchinson et al., "Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects," The American Review of Respiratory Disease, vol.